Research Article

Lipoprotein(a) Is the Best Single Marker in Assessing Unstable Angina Pectoris

Table 5

The results of ROC curves analysis of lipid markers in ischemic heart disease patients.

AUCSE95%CISpecificitySensitivityCriterion

SAPApoA-I 0 . 7 8 0 a 0.0650.660–0.87371.877.3 ≤1.28
ApoB 0 . 5 4 2 b 0.0760.414–0.66692.338.6 ≤0.9
LDL-c 0 . 5 3 9 b 0.0760.411–0.66487.240.9 ≤3.06
Lp(a) 0 . 8 3 5 c 0.0490.722–0.91580.081.8>8.2
oxLDL0.5520.0750.423–0.67580.043.2 >280
TG0.7040.0650.578–0.81148.786.4 >1.31

USAPApoA-I 0 . 8 7 6 C 0.0510.773–0.94471.891.3 ≤1.28
ApoB0.5570.0740.430–0.67889.721.7 >1.41
LDL-c0.5880.0750.461–0.70764.160.9 ≤3.49
Lp(a) 0 . 9 5 1 B 0.0250.869–0.98884.097.9>8.2
oxLDL0.5290.0750.403–0.65293.332.6 >460
TG 0 . 7 4 2 A 0.0600.621–0.84171.869.6 >1.94

STEMIApoA-I 0 . 8 3 6 0.0570.732–0.91171.883.6 ≤1.26
ApoB 0 . 6 2 6 0.0680.506–0.73589.730.9 >1.41
LDL-c0.5140.0730.395–0.63187.225.5 ≤3.07
Lp(a) 0 . 8 8 1 / 0.0380.785–0.99484.084.9>8.2
oxLDL0.5050.0740.387–0.62396.724.5 >4.80
TG0.664*0.0650.546–0.76956.469.1 >1.49

a 𝑃 < . 0 5 versus LDL-c and oxLDL, b 𝑃 < . 0 5 versus TG, c 𝑃 < . 0 0 1 versus oxLDL, LDL-c and ApoB, A 𝑃 < . 0 5 versus ApoB and OxLDL, B 𝑃 < . 0 0 1 versus LDL-c, oxLDL, ApoB and TG, C 𝑃 < . 0 0 1 versus ApoB, LDL-c and oxLDL, 𝑃 < . 0 5 versus ApoA, LDL-c, 𝑃 < 0 . 0 1 versus ApoA, LDL-c, 𝑃 < . 0 1 versus TG, 𝑃 < . 0 0 1 versus LDL-c, oxLDL, 𝑃 < . 0 0 1 versus ApoB, LDL-c, OxLDL.